Literature DB >> 33205329

Editorial: 18F-Fluoride PET/MR in cardiac amyloid; simple addition versus synergy?

Sarah A M Cuddy1,2.   

Abstract

Entities:  

Year:  2020        PMID： 33205329     DOI： 10.1007/s12350-020-02437-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  15 in total

1.  Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?

Authors:  Sarah A M Cuddy; Paco E Bravo; Rodney H Falk; Samir El-Sady; Marie Foley Kijewski; Mi-Ae Park; Frederick L Ruberg; Vaishali Sanchorawala; Heather Landau; Andrew J Yee; Giada Bianchi; Marcelo F Di Carli; Su-Chun Cheng; Michael Jerosch-Herold; Raymond Y Kwong; Ronglih Liao; Sharmila Dorbala
Journal:  JACC Cardiovasc Imaging       Date:  2020-05-13

2.  Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.

Authors:  David Adams; Alejandra Gonzalez-Duarte; William D O'Riordan; Chih-Chao Yang; Mitsuharu Ueda; Arnt V Kristen; Ivailo Tournev; Hartmut H Schmidt; Teresa Coelho; John L Berk; Kon-Ping Lin; Giuseppe Vita; Shahram Attarian; Violaine Planté-Bordeneuve; Michelle M Mezei; Josep M Campistol; Juan Buades; Thomas H Brannagan; Byoung J Kim; Jeeyoung Oh; Yesim Parman; Yoshiki Sekijima; Philip N Hawkins; Scott D Solomon; Michael Polydefkis; Peter J Dyck; Pritesh J Gandhi; Sunita Goyal; Jihong Chen; Andrew L Strahs; Saraswathy V Nochur; Marianne T Sweetser; Pushkal P Garg; Akshay K Vaishnaw; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2018-07-05       Impact factor: 91.245

3.  Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.

Authors:  Merrill D Benson; Márcia Waddington-Cruz; John L Berk; Michael Polydefkis; Peter J Dyck; Annabel K Wang; Violaine Planté-Bordeneuve; Fabio A Barroso; Giampaolo Merlini; Laura Obici; Morton Scheinberg; Thomas H Brannagan; William J Litchy; Carol Whelan; Brian M Drachman; David Adams; Stephen B Heitner; Isabel Conceição; Hartmut H Schmidt; Giuseppe Vita; Josep M Campistol; Josep Gamez; Peter D Gorevic; Edward Gane; Amil M Shah; Scott D Solomon; Brett P Monia; Steven G Hughes; T Jesse Kwoh; Bradley W McEvoy; Shiangtung W Jung; Brenda F Baker; Elizabeth J Ackermann; Morie A Gertz; Teresa Coelho
Journal:  N Engl J Med       Date:  2018-07-05       Impact factor: 91.245

4.  [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.

Authors:  Dario Genovesi; Giuseppe Vergaro; Assuero Giorgetti; Paolo Marzullo; Michele Scipioni; Maria Filomena Santarelli; Angela Pucci; Gabriele Buda; Elisabetta Volpi; Michele Emdin
Journal:  JACC Cardiovasc Imaging       Date:  2020-08-05

5.  18F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis.

Authors:  Maria Giovanna Trivieri; Marc R Dweck; Ronan Abgral; Philip M Robson; Nicolas A Karakatsanis; Anuradha Lala; Johanna Contreras; Gagan Sahni; Radha Gopalan; Peter Gorevic; Valentin Fuster; Jagat Narula; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2016-12-20       Impact factor: 24.094

6.  18F-flutemetamol positron emission tomography in cardiac amyloidosis.

Authors:  Maria Papathanasiou; Peter Luedike; Christoph Rischpler; Lukas Kessler; Alexander Carpinteiro; Tim Hagenacker; Felix Nensa; Lale Umutlu; Michael Forsting; Alexandra Brainman; Christoph Kleinschnitz; Gerald Antoch; Ulrich Dührsen; Thomas-Wilfried Schlosser; Ken Herrmann; Tienush Rassaf
Journal:  J Nucl Cardiol       Date:  2020-10-06       Impact factor: 5.952

7.  Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Authors:  Mathew S Maurer; Jeffrey H Schwartz; Balarama Gundapaneni; Perry M Elliott; Giampaolo Merlini; Marcia Waddington-Cruz; Arnt V Kristen; Martha Grogan; Ronald Witteles; Thibaud Damy; Brian M Drachman; Sanjiv J Shah; Mazen Hanna; Daniel P Judge; Alexandra I Barsdorf; Peter Huber; Terrell A Patterson; Steven Riley; Jennifer Schumacher; Michelle Stewart; Marla B Sultan; Claudio Rapezzi
Journal:  N Engl J Med       Date:  2018-08-27       Impact factor: 91.245

8.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

9.  Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.

Authors:  Agnese Irkle; Alex T Vesey; David Y Lewis; Jeremy N Skepper; Joseph L E Bird; Marc R Dweck; Francis R Joshi; Ferdia A Gallagher; Elizabeth A Warburton; Martin R Bennett; Kevin M Brindle; David E Newby; James H Rudd; Anthony P Davenport
Journal:  Nat Commun       Date:  2015-07-07       Impact factor: 14.919

10.  18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

Authors:  Nikhil V Joshi; Alex T Vesey; Michelle C Williams; Anoop S V Shah; Patrick A Calvert; Felicity H M Craighead; Su Ern Yeoh; William Wallace; Donald Salter; Alison M Fletcher; Edwin J R van Beek; Andrew D Flapan; Neal G Uren; Miles W H Behan; Nicholas L M Cruden; Nicholas L Mills; Keith A A Fox; James H F Rudd; Marc R Dweck; David E Newby
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.